Clinical Trial: Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Safety and Efficacy of Alitretinoin in the Treatment of Severe Refractory Chronic Hand Dermatitis

Brief Summary: Patients with severe chronic hand dermatitis, that has not responded to topical treatment, including topical steroids and the avoidance of aggravating factors, will be treated with the oral medication alitretinoin. The study aims to investigate the safety and efficacy of the medication when given over a period of 6 months.